Skip to main content
. 2017 Nov 15;2(11):1187–1196. doi: 10.1001/jamacardio.2017.3705

Table. Baseline Patient Characteristics of the Overall Study Cohort Before and After PS Weighting.

Characteristic MAG,a No. (%)
(n = 5580)
LITA+SVG
(n = 14 496)
Standardized Difference
Before PS Weighting,a No. (%) After PS Weighting,b % Before PS Weightingc After PS Weightingc
Age at surgery, mean (SD), y 60.0 (8.7) 68.0 (8.9) 60.3 (8.5) 0.916 0.039
Female sex 586 (10.5) 2803 (19.3) 10.6 0.288 0.004
Ejection fraction, <35% 278 (5.0) 1383 (9.5) 5.1 0.210 0.006
Ejection fraction, 35%-50% 1914 (34.3) 5416 (37.4) 33.4 0.064 0.018
Ejection-fraction, >50% 3388 (60.7) 7697 (53.1) 61.5 0.156 0.015
BMI
<18.5 10 (0.2) 99 (0.7) 0.2 0.119 0
18.5-29 3785 (67.8) 10001 (69.0) 67.9 0.025 0.001
30-34 1349 (24.2) 3188 (22.0) 24.2 0.051 0.001
>35 436 (7.8) 1208 (8.3) 7.7 0.019 0.003
Urgent statusd 1549 (27.8) 3385 (23.4) 27.8 0.098 0.002
CCS class IV 2529 (45.3) 6194 (42.7) 44.9 0.052 0.008
NYHA IV 99 (1.8) 304 (2.1) 1.5 0.024 0.019
Left main disease 1785 (32.0) 4331 (29.9) 32.2 0.045 0.004
Previous PCI 948 (17.0) 2629 (18.1) 17.0 0.031 0.001
Prior myocardial infarction 3085 (55.3) 8945 (61.7) 55.2 0.129 0.002
Preoperative arrhythmia 227 (4.1) 1077 (7.4) 4.2 0.170 0.005
History of heart failure 453 (8.1) 2339 (16.1) 8.0 0.294 0.003
Hypertension 4224 (75.7) 12060 (83.2) 76.0 0.175 0.006
Pulmonary hypertension 100 (1.8) 630 (4.3) 1.9 0.192 0.006
PVD 559 (10.0) 2559 (17.7) 10.0 0.254 0.001
COPD 816 (14.6) 3028 (20.9) 14.7 0.177 0.003
Cerebrovascular diseasee 318 (5.7) 1919 (13.2) 5.7 0.325 0.002
Renal disease, normalf 4600 (82.4) 10056 (69.4) 82.4 0.343 0
Renal disease, dysfunctionf 854 (15.3) 3510 (24.2) 15.3 0.247 0.001
Renal disease, failure without dialysisf 90 (1.6) 696 (4.8) 1.6 0.253 0.001
Renal disease, dialysisf 36 (0.6) 234 (1.6) 0.7 0.121 0.001
Diabetes 1650 (29.6) 5771 (39.8) 29.5 0.224 0.002
Cancer within 5 y 148 (2.7) 701 (4.8) 2.7 0.136 0.002
Liver disease 378 (6.8) 1272 (8.8) 6.8 0.080 0.003
Moderate/severe anemiag 156 (2.8) 1048 (7.2) 2.9 0.269 0.004
Current/recent smoking within 1 mo 988 (17.7) 2013 (13.9) 17.4 0.100 0.007

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CCS class, Canadian Cardiovascular Society Functional Classification of Angina; COPD, chronic obstructive pulmonary disease; LITA+SVG, left internal thoracic artery supplemented by saphenous vein grafts; MAG, multiple arterial grafting; NYHA class, New York Heart Association Class; PCI, percutaneous coronary intervention; PS, propensity score; PVD, peripheral vascular disease.

SI conversion factor: To convert hemoglobin to grams per liter, multiply by 10).

a

Data are expressed as number (%) of patients unless otherwise indicated.

b

Data are expressed as weighted percentage unless otherwise indicated.

c

The standardized differences of <0 .1 indicate adequate balance of the distribution of baseline risk between the 2 groups.

d

Urgent status indicates any instances when the patient had left main stenosis greater than 70%, unstable angina receiving nitroglycerin/heparin drip.

e

Cerebrovascular disease is defined as cerebrovascular accident or transient ischemic attack.

f

Renal disease is any documented history of renal disease diagnosed including dialysis, acute or chronic renal failure, or estimated glomerular filtration rate less than 60 mL/min/1.73m2 (by the Cockcroft-Gault formula). Dialysis: patient is currently undergoing either hemodialysis or peritoneal dialysis. Failure without dialysis: acute or chronic renal failure or estimated glomerular filtration rate less than 15 mL/min/1.73m2 without dialysis. Dysfunction estimated glomerular filtration rate between 15 and 60 mL/min/1.73m2.

g

Moderate/severe anemia is defined as hemoglobin level less than 11 g/dL.